Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: A multicenter study

Journal article

Steinacker P. et al, (2020), Amyotrophic lateral sclerosis & frontotemporal degeneration

Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS

Journal article

Oeckl P. et al, (2016), Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17, 404 - 413

Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers

Journal article

Thompson AG. et al, (2016), Nature Reviews Neurology, 12, 346 - 357

Are neurofilaments heading for the ALS clinic?

Journal article

Turner MR. and Gray E., (2016), Journal of Neurology, Neurosurgery & Psychiatry

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis

Journal article

Gray E. et al, (2015), Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16, 456 - 463

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS

Journal article

Menke RAL. et al, (2015), Annals of Clinical and Translational Neurology, 2, 748 - 755